590 related articles for article (PubMed ID: 28851447)
1. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.
Dufouil C; Dubois B; Vellas B; Pasquier F; Blanc F; Hugon J; Hanon O; Dartigues JF; Harston S; Gabelle A; Ceccaldi M; Beauchet O; Krolak-Salmon P; David R; Rouaud O; Godefroy O; Belin C; Rouch I; Auguste N; Wallon D; Benetos A; Pariente J; Paccalin M; Moreaud O; Hommet C; Sellal F; Boutoleau-Bretonniére C; Jalenques I; Gentric A; Vandel P; Azouani C; Fillon L; Fischer C; Savarieau H; Operto G; Bertin H; Chupin M; Bouteloup V; Habert MO; Mangin JF; Chêne G;
Alzheimers Res Ther; 2017 Aug; 9(1):67. PubMed ID: 28851447
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
4. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
[TBL] [Abstract][Full Text] [Related]
7. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
9. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
10. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.
Yu Y; Zhao W; Li S; Yin C
BMJ Open; 2017 Mar; 7(3):e013432. PubMed ID: 28274963
[TBL] [Abstract][Full Text] [Related]
11. Alteration of regional homogeneity and white matter hyperintensities in amnestic mild cognitive impairment subtypes are related to cognition and CSF biomarkers.
Luo X; Jiaerken Y; Huang P; Xu XJ; Qiu T; Jia Y; Shen Z; Guan X; Zhou J; Zhang M;
Brain Imaging Behav; 2018 Feb; 12(1):188-200. PubMed ID: 28236166
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
13. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
[TBL] [Abstract][Full Text] [Related]
14. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
[TBL] [Abstract][Full Text] [Related]
16. Are transversal MR images sufficient to distinguish persons with mild cognitive impairment from healthy controls?
Mönninghoff C; Dlugaj M; Kraff O; Geisel MH; Jöckel KH; Erbel R; Weimar C; Wanke I;
Acad Radiol; 2015 Sep; 22(9):1172-80. PubMed ID: 26162248
[TBL] [Abstract][Full Text] [Related]
17. Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment.
Yoon HJ; Park KW; Jeong YJ; Kang DY
Nucl Med Commun; 2012 Aug; 33(8):848-58. PubMed ID: 22692580
[TBL] [Abstract][Full Text] [Related]
18. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
[TBL] [Abstract][Full Text] [Related]
19. Data-driven prognostic features of cognitive trajectories in patients with amnestic mild cognitive impairments.
Kim YJ; Cho SK; Kim HJ; Lee JS; Lee J; Jang YK; Vogel JW; Na DL; Kim C; Seo SW
Alzheimers Res Ther; 2019 Jan; 11(1):10. PubMed ID: 30670089
[TBL] [Abstract][Full Text] [Related]
20. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
